Dice Thinks It Holds An Ace With Oral IL-17 Inhibitor In Psoriasis

 
• By Jessica Merrill
  
dice
Dice Therapeutics' oral IL-17 inhibitor showed encouraging early data • Source: Shutterstock

More from Clinical Trials

More from R&D